OBJECT: The purpose of this study was to define the incidence of permanent shunt placement and infection in patients who have undergone the 2 most commonly performed temporizing procedures for posthemorrhagic hydrocephalus (PHH) of prematurity: ventriculosubgaleal (VSG) shunt placement and ventricular reservoir placement for intermittent tapping. METHODS: The 4 centers of the Hydrocephalus Clinical Research Network participated in a retrospective chart review of infants with PHH who underwent treatment at each institution between 2001 and 2006. Patients were included if they had received a diagnosis of Grade 3 or 4 intraventricular hemorrhage, weighed < 1500 g at birth, and had received surgical intervention. The authors determined the incidence of conversion from a temporizing device to a permanent shunt, the incidence of CSF infection during temporization, and the 6-month CSF infection rate after permanent shunt placement. RESULTS: Thirty-one (86%) of 36 patients who received VSG shunts and 61 (69%) of 88 patients who received ventricular reservoirs received permanent CSF diversion with a shunt (p = 0.05). Five patients (14%) in the VSG shunt group had CSF infections during temporization, compared with 11 patients (13%) in the ventricular reservoir group (p = 0.83). The 6-month incidence of permanent shunt infection in the VSG shunt group was 16% (5 of 31), compared with 12% (7 of 61) in the reservoir placement group (p = 0.65). For the first 6 months after permanent shunt placement, infants with no preceding temporizing procedure had an infection rate of 5% (1 of 20 infants) and those who had undergone a temporizing procedure had an infection rate of 13% (12 of 92; p = 0.45). CONCLUSIONS: The use of intermittent tapping of ventricular reservoirs in this population appears to lead to a lower incidence of permanent shunt placement than the use of VSG shunts. The incidence of infection during temporization and for the initial 6 months after conversion appears comparable for both groups. The apparent difference identified in this pilot study requires confirmation in a more rigorous study.
OBJECT: The purpose of this study was to define the incidence of permanent shunt placement and infection in patients who have undergone the 2 most commonly performed temporizing procedures for posthemorrhagic hydrocephalus (PHH) of prematurity: ventriculosubgaleal (VSG) shunt placement and ventricular reservoir placement for intermittent tapping. METHODS: The 4 centers of the Hydrocephalus Clinical Research Network participated in a retrospective chart review of infants with PHH who underwent treatment at each institution between 2001 and 2006. Patients were included if they had received a diagnosis of Grade 3 or 4 intraventricular hemorrhage, weighed < 1500 g at birth, and had received surgical intervention. The authors determined the incidence of conversion from a temporizing device to a permanent shunt, the incidence of CSF infection during temporization, and the 6-month CSF infection rate after permanent shunt placement. RESULTS: Thirty-one (86%) of 36 patients who received VSG shunts and 61 (69%) of 88 patients who received ventricular reservoirs received permanent CSF diversion with a shunt (p = 0.05). Five patients (14%) in the VSG shunt group had CSF infections during temporization, compared with 11 patients (13%) in the ventricular reservoir group (p = 0.83). The 6-month incidence of permanent shunt infection in the VSG shunt group was 16% (5 of 31), compared with 12% (7 of 61) in the reservoir placement group (p = 0.65). For the first 6 months after permanent shunt placement, infants with no preceding temporizing procedure had an infection rate of 5% (1 of 20 infants) and those who had undergone a temporizing procedure had an infection rate of 13% (12 of 92; p = 0.45). CONCLUSIONS: The use of intermittent tapping of ventricular reservoirs in this population appears to lead to a lower incidence of permanent shunt placement than the use of VSG shunts. The incidence of infection during temporization and for the initial 6 months after conversion appears comparable for both groups. The apparent difference identified in this pilot study requires confirmation in a more rigorous study.
Authors: R Shane Tubbs; Matthew D Smyth; John C Wellons; Jeffrey P Blount; Paul A Grabb; W Jerry Oakes Journal: Pediatr Neurosurg Date: 2003-05 Impact factor: 1.162
Authors: Matthew J McGirt; Jean-Christophe Leveque; John C Wellons; Alan T Villavicencio; John S Hopkins; Herbert E Fuchs; Timoth M George Journal: Pediatr Neurosurg Date: 2002-05 Impact factor: 1.162
Authors: Thomas Looi; Karolina Piorkowska; Charles Mougenot; Adam Waspe; Kullervo Hynynen; James Drake Journal: Childs Nerv Syst Date: 2018-05-23 Impact factor: 1.475
Authors: Vincent de paul Djientcheu; Seraphin Nguefack; T Olivier Mouafo; A Stephane Mbarnjuk; T Yves Yamgoue; Figuim Bello; Giles Kagmeni; Elie Mbonda; Benedict Rilliet Journal: Childs Nerv Syst Date: 2011-08-07 Impact factor: 1.475
Authors: Tamara D Simon; Kathryn B Whitlock; Jay Riva-Cambrin; John R W Kestle; Margaret Rosenfeld; J Michael Dean; Richard Holubkov; Marcie Langley; Nicole Mayer-Hamblett Journal: J Neurosurg Pediatr Date: 2012-01 Impact factor: 2.375
Authors: L Romero; B Ros; F Ríus; L González; J M Medina; A Martín; A Carrasco; M A Arráez Journal: Childs Nerv Syst Date: 2013-07-24 Impact factor: 1.475
Authors: Rowland H Han; Andrew McKinnon; Travis S CreveCoeur; Brandon S Baksh; Amit M Mathur; Christopher D Smyser; Jennifer M Strahle; Margaret A Olsen; David D Limbrick Journal: Childs Nerv Syst Date: 2018-07-09 Impact factor: 1.475
Authors: Jay Riva-Cambrin; Chevis N Shannon; Richard Holubkov; William E Whitehead; Abhaya V Kulkarni; James Drake; Tamara D Simon; Samuel R Browd; John R W Kestle; John C Wellons Journal: J Neurosurg Pediatr Date: 2012-05 Impact factor: 2.375